Narasin

Star0

DB11432ExperimentalVet approvedSmall molecule

Narasin is an agent with coccidiostatic and antibacterial properties.

Formula / weight: C₄₃H₇₂O₁₁ · 765.038 g/mol (avg)
Also known as: Narasin A
Code names: C-7819B · COMPD-79891 · Lilly 79891

Resolves to

Compound

UNIIDZY9VU539PCAS55134-13-9ChEMBLCHEMBL2104423KEGGD05122

Clinical / RWD

RxNorm1314370

Structure

InChIKeyVHKXXVVRRDYCIK-CWCPJSEDSA-NSMILES

[H][C@@]1(CC[C@](O)(CC)[C@H](C)O1)[C@]1(C)CC[C@]2(O1)O[C@@]1(O[C@]([H])([C@@H](CC)C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@]3([H])O[C@@]([H])([C@@H](CC)C(O)=O)[C@@H](C)C[C@@H]3C)[C@@H](C)C[C@H]1C)C=C[C@H]2O

What you can answer from here — as of February 21, 2021

56Drug interactionsStructured to mechanism, not free text

1Marketed productAcross 1 country and 1 labeller

10+ReferencesStructured and connected to the statements they support

Which companies are running trials of Narasin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account